TI
FENC icon

Trexquant Investment’s Fennec Pharmaceuticals FENC Stock Holding History

Trexquant Investment’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$319K Buy
51,869
+489
+1% +$3.77K ﹤0.01% 1581
2025
Q4 		$396K Buy
+51,380
New +$422K ﹤0.01% 1393

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Trexquant Investment's FENC Position: Q1 2026 in Review

Trexquant Investment increased its Fennec Pharmaceuticals (FENC) stake by 0.95% in Q1 2026, buying an estimated $3.77K and bringing the position to 51,869 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Trexquant Investment first reported a position in FENC in Q4 2025 and has held it in 2 quarters since. The position peaked at $396K in Q4 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Trexquant Investment held 51,869 shares of Fennec Pharmaceuticals worth $319K as of Q1 2026.
  • Trexquant Investment bought 489 Fennec Pharmaceuticals shares in Q1 2026, an estimated $3.77K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1581 holding.
  • Trexquant Investment first reported a position in Fennec Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Trexquant Investment's Fennec Pharmaceuticals position peaked at $396K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.